Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michalis V Karamouzis

Showing results (1-10 of 157) with videos related to

Pageof 16
Sort By:
Thrombosis Research|October 10, 2022
The impact of thromboprophylaxis with LMWHs on the survival of patients with pancreatic cancerPanagiotis Sarantis, Michalis V Karamouzis
Cancer Treatment and Research|October 24, 2007
Update on the role of EGFR inhibitors in cancer therapeuticsMichalis V Karamouzis, Athanassios Argiris
Cancer|November 5, 2013
Tackling the cancer signal transduction “labyrinth”: a combinatorial use of biochemical tools with mathematical models will enhance the identification of optimal targets for each molecular defectMichalis V Karamouzis, Athanasios G Papavassiliou
Cancer Metastasis Reviews|September 8, 2010
DNA repair pathways and their implication in cancer treatmentAthanasios G Pallis, Michalis V Karamouzis
ESMO Open|April 24, 2018
Response: <i>Effects of physical activity on depressive symptoms during breast cancer survivorship: a meta-analysis of randomised control trials</i>Efrossini D Patsou, Michalis V Karamouzis
Expert Opinion on Biological Therapy|April 17, 2009
The use of endostatin in the treatment of solid tumorsMichalis V Karamouzis, Stergios J Moschos
Trends in Molecular Medicine|January 15, 2005
Retinoid receptor cross-talk in respiratory epithelium cancer chemopreventionMichalis V Karamouzis, Athanasios G Papavassiliou
Expert Opinion on Investigational Drugs|June 30, 2018
Combination of checkpoint inhibitors with other agents as a strategy to improve anti-cancer effect - a glimpse to the futureMichalis V Karamouzis, Athanasios G Papavassiliou
Critical Reviews in Oncology/Hematology|March 20, 2012
Targeting insulin-like growth factor in breast cancer therapeuticsMichalis V Karamouzis, Athanasios G Papavassiliou
Molecular Medicine (Cambridge, Mass.)|September 14, 2011
Transcription factor networks as targets for therapeutic intervention of cancer: the breast cancer paradigmMichalis V Karamouzis, Athanasios G Papavassiliou
Pageof 16

Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
Thrombosis Research|October 10, 2022
The impact of thromboprophylaxis with LMWHs on the survival of patients with pancreatic cancerPanagiotis Sarantis, Michalis V Karamouzis
Cancer Treatment and Research|October 24, 2007
Update on the role of EGFR inhibitors in cancer therapeuticsMichalis V Karamouzis, Athanassios Argiris
Cancer|November 5, 2013
Tackling the cancer signal transduction “labyrinth”: a combinatorial use of biochemical tools with mathematical models will enhance the identification of optimal targets for each molecular defectMichalis V Karamouzis, Athanasios G Papavassiliou
Cancer Metastasis Reviews|September 8, 2010
DNA repair pathways and their implication in cancer treatmentAthanasios G Pallis, Michalis V Karamouzis
ESMO Open|April 24, 2018
Response: <i>Effects of physical activity on depressive symptoms during breast cancer survivorship: a meta-analysis of randomised control trials</i>Efrossini D Patsou, Michalis V Karamouzis
Expert Opinion on Biological Therapy|April 17, 2009
The use of endostatin in the treatment of solid tumorsMichalis V Karamouzis, Stergios J Moschos
Trends in Molecular Medicine|January 15, 2005
Retinoid receptor cross-talk in respiratory epithelium cancer chemopreventionMichalis V Karamouzis, Athanasios G Papavassiliou
Expert Opinion on Investigational Drugs|June 30, 2018
Combination of checkpoint inhibitors with other agents as a strategy to improve anti-cancer effect - a glimpse to the futureMichalis V Karamouzis, Athanasios G Papavassiliou
Critical Reviews in Oncology/Hematology|March 20, 2012
Targeting insulin-like growth factor in breast cancer therapeuticsMichalis V Karamouzis, Athanasios G Papavassiliou
Molecular Medicine (Cambridge, Mass.)|September 14, 2011
Transcription factor networks as targets for therapeutic intervention of cancer: the breast cancer paradigmMichalis V Karamouzis, Athanasios G Papavassiliou
Pageof 16